Last reviewed 2026-04-19 · How we verify

Unknown indication

Approved treatments

• omeprazole, 20mg twice daily · Tel-Aviv Sourasky Medical Center
  Omeprazole reduces stomach acid production by irreversibly inhibiting the H+/K+ ATPase enzyme in gastric parietal cells.
• omeprazole, 20mg twice daily · Tel-Aviv Sourasky Medical Center
  Omeprazole reduces stomach acid production by irreversibly inhibiting the H+/K+ ATPase enzyme in gastric parietal cells.
• omeprazole, 20mg twice daily · Tel-Aviv Sourasky Medical Center
  Omeprazole reduces stomach acid production by irreversibly inhibiting the H+/K+ ATPase enzyme in gastric parietal cells.
• 0.33% ropivacaine 250ml · Guangzhou General Hospital of Guangzhou Military Command
  Ropivacaine is a local anesthetic that blocks sodium channels, preventing the propagation of nerve impulses.
• 0.33% ropivacaine 250ml · Guangzhou General Hospital of Guangzhou Military Command
  Ropivacaine is a local anesthetic that blocks sodium channels, preventing the propagation of nerve impulses.
• NICARDIPINE HYDROCHLORIDE
  Nicardipine blocks calcium ion influx into vascular smooth muscle, causing relaxation with minimal effect on cardiac muscle.
• NICARDIPINE HYDROCHLORIDE
  Nicardipine blocks calcium ion influx into vascular smooth muscle, causing relaxation with minimal effect on cardiac muscle.
• Experimental: Active "I-Reconstruction" Therapy · International Association Psychosomatics And Health Therapy
  Ofloxacin ophthalmic solution is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, leading to bacterial cell death.
• INOTUZUMAB OZOGAMICIN
  Inotuzumab ozogamicin is a CD22-directed antibody-drug conjugate that binds to CD22 on tumor cells, internalizes, and releases a cytotoxic agent causing DNA damage and cell death.
• Lidocaine patch local application · Taipei Medical University Hospital
  Lidocaine patch works by locally blocking sodium channels in nerve cells, which reduces the transmission of pain signals.
• Lamiduvine (Epivir) · Catholic University of the Sacred Heart
  Lamiduvine inhibits the HIV reverse transcriptase enzyme, preventing viral RNA from being converted into DNA, thus halting viral replication.
• Ceftriaxone v penicillin and gentamicin · Kamuzu University of Health Sciences
  Ceftriaxone inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs).
• Ceftriaxone v penicillin and gentamicin · Kamuzu University of Health Sciences
  Ceftriaxone inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs).
• Ceftriaxone v penicillin and gentamicin · Kamuzu University of Health Sciences
  Ceftriaxone inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs).
• Ceftriaxone v penicillin and gentamicin · Kamuzu University of Health Sciences
  Ceftriaxone inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs).
• Ceftriaxone v penicillin and gentamicin · Kamuzu University of Health Sciences
  Ceftriaxone inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs).
• Ceftriaxone v penicillin and gentamicin · Kamuzu University of Health Sciences
  Ceftriaxone inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs).
• Captopril Test Dose and Trandolapril · Rigshospitalet, Denmark
  Captopril and Trandolapril inhibit the angiotensin-converting enzyme (ACE), reducing the formation of angiotensin II and leading to vasodilation and decreased blood pressure.
• Captopril Test Dose and Trandolapril · Rigshospitalet, Denmark
  Captopril and Trandolapril inhibit the angiotensin-converting enzyme (ACE), reducing the formation of angiotensin II and leading to vasodilation and decreased blood pressure.
• BiDil XR · Arbor Pharmaceuticals, Inc.
  BiDil XR combines isosorbide dinitrate and hydralazine to enhance vasodilation and reduce cardiac workload, specifically benefiting patients with heart failure.
• Drug treatment with Cymbalta · Jefferson Clinic, P.C.
  Cymbalta is a serotonin-norepinephrine reuptake inhibitor (SNRI) that increases the levels of serotonin and norepinephrine in the brain.
• Drug treatment with Cymbalta · Jefferson Clinic, P.C.
  Cymbalta is a serotonin-norepinephrine reuptake inhibitor (SNRI) that increases the levels of serotonin and norepinephrine in the brain.
• Drug treatment with Cymbalta · Jefferson Clinic, P.C.
  Cymbalta is a serotonin-norepinephrine reuptake inhibitor (SNRI) that increases the levels of serotonin and norepinephrine in the brain.
• Drug treatment with Cymbalta · Jefferson Clinic, P.C.
  Cymbalta is a serotonin-norepinephrine reuptake inhibitor (SNRI) that increases the levels of serotonin and norepinephrine in the brain.
• Drug treatment with Cymbalta · Jefferson Clinic, P.C.
  Cymbalta is a serotonin-norepinephrine reuptake inhibitor (SNRI) that increases the levels of serotonin and norepinephrine in the brain.
• Attenuated Hepatitis A Vaccine, H2 Strain · Jiangsu Province Centers for Disease Control and Prevention
  The Attenuated Hepatitis A Vaccine, H2 Strain, works by introducing a live, weakened form of the hepatitis A virus to stimulate an immune response.
• Fluvastatin, Tacrolimus, Mycophenolat Mofetil · University Hospital Schleswig-Holstein
  Fluvastatin, Tacrolimus, and Mycophenolate Mofetil work through different mechanisms to manage hypercholesterolemia and prevent organ rejection in transplant patients.
• Fluvastatin, Tacrolimus, Mycophenolat Mofetil · University Hospital Schleswig-Holstein
  Fluvastatin, Tacrolimus, and Mycophenolate Mofetil work through different mechanisms to manage hypercholesterolemia and prevent organ rejection in transplant patients.
• Fluvastatin, Tacrolimus, Mycophenolat Mofetil · University Hospital Schleswig-Holstein
  Fluvastatin, Tacrolimus, and Mycophenolate Mofetil work through different mechanisms to manage hypercholesterolemia and prevent organ rejection in transplant patients.
• Montelukast (High FeNO group) · Hull University Teaching Hospitals NHS Trust
  Montelukast is a selective leukotriene receptor antagonist that blocks the action of cysteinyl leukotrienes on the CysLT1 receptor, reducing inflammation and bronchoconstriction.
• Montelukast (High FeNO group) · Hull University Teaching Hospitals NHS Trust
  Montelukast is a selective leukotriene receptor antagonist that blocks the action of cysteinyl leukotrienes on the CysLT1 receptor, reducing inflammation and bronchoconstriction.
• Actos (Pioglitazone) · Taipei Veterans General Hospital, Taiwan
  Actos (pioglitazone) is a thiazolidinedione that enhances insulin sensitivity in peripheral tissues, particularly in adipose tissue, skeletal muscle, and liver.
• flunarizine and/or pregabalin · Taipei Veterans General Hospital, Taiwan
  Flunarizine blocks voltage-dependent calcium channels, while pregabalin binds to the alpha2-delta subunit of voltage-gated calcium channels, reducing the release of neurotransmitters.
• flunarizine and/or pregabalin · Taipei Veterans General Hospital, Taiwan
  Flunarizine blocks voltage-dependent calcium channels, while pregabalin binds to the alpha2-delta subunit of voltage-gated calcium channels, reducing the release of neurotransmitters.
• fluticasone propionate hydrofluoroalkane (HFA) · Organon and Co
  Fluticasone propionate HFA is a potent inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors.
• fluticasone propionate hydrofluoroalkane (HFA) · Organon and Co
  Fluticasone propionate HFA is a potent inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors.
• Tetanus Toxoid Reduced Diphtheria Toxoid Acellular Pertussis · Sanofi Pasteur, a Sanofi Company
  The Tdap vaccine works by introducing inactivated toxins from the bacteria that cause tetanus, diphtheria, and pertussis, stimulating the immune system to produce antibodies against these pathogens.
• Bufomix® Easyhaler® 160/4.5 µg/inhalation dmDPI · Orion Corporation, Orion Pharma
  Bufomix® Easyhaler® combines an inhaled corticosteroid (ICS) and a long-acting beta2-adrenergic agonist (LABA) to reduce inflammation and bronchodilation in the airways.
• Bufomix® Easyhaler® 160/4.5 µg/inhalation dmDPI · Orion Corporation, Orion Pharma
  Bufomix® Easyhaler® combines an inhaled corticosteroid (ICS) and a long-acting beta2-adrenergic agonist (LABA) to reduce inflammation and bronchodilation in the airways.
• semaglutide or tirzepatide · Mayo Clinic
  Semaglutide and tirzepatide are GLP-1 receptor agonists that enhance glucose-dependent insulin secretion and reduce glucagon secretion, leading to improved glycemic control and weight loss.
• semaglutide or tirzepatide · Mayo Clinic
  Semaglutide and tirzepatide are GLP-1 receptor agonists that enhance glucose-dependent insulin secretion and reduce glucagon secretion, leading to improved glycemic control and weight loss.
• Onasemnogene Abeparvovec-brve · Novartis Pharmaceuticals
  ITVISMA delivers a functional SMN1 gene using an AAV9 vector to promote SMN protein expression in motor neurons.
• epoetin · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  Epogen stimulates erythropoiesis by the same mechanism as endogenous erythropoietin.
• epoetin · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  Epogen stimulates erythropoiesis by the same mechanism as endogenous erythropoietin.
• Tegoprazan 50 mg · First People's Hospital of Hangzhou
  Tegoprazan is a potassium-competitive acid blocker (P-CAB) that inhibits the H+/K+-ATPase enzyme, reducing gastric acid secretion.
• Tegoprazan 50 mg · First People's Hospital of Hangzhou
  Tegoprazan is a potassium-competitive acid blocker (P-CAB) that inhibits the H+/K+-ATPase enzyme, reducing gastric acid secretion.
• FluMist Quadrivalent (2017-2018) · MedImmune LLC
  FluMist Quadrivalent is a live attenuated influenza vaccine that stimulates an immune response in the nasal passages to prevent influenza infection.
• epoetin · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  Epogen stimulates erythropoiesis by the same mechanism as endogenous erythropoietin.
• MenC · Novartis Vaccines
  MenC stimulates the immune system to produce antibodies against the capsular polysaccharide of Neisseria meningitidis serogroup C.
• epoetin · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  Epogen stimulates erythropoiesis by the same mechanism as endogenous erythropoietin.

Pipeline

• PF-06939999 in combination with docetaxel · Pfizer
• Pitavastin 4mg · University of Kansas Medical Center
• Pitavastin 4mg · University of Kansas Medical Center
• Ga-68-DOTATOC · Weill Medical College of Cornell University
• AVACINCAPTAD PEGOL SODIUM
• AVACINCAPTAD PEGOL SODIUM
• Insulin injections · University of Campania Luigi Vanvitelli
• Twinrix for ATN 025 · University of North Carolina, Chapel Hill
• Anti-VEGF drug · Xiaodong Sun
• Anti-VEGF drug · Xiaodong Sun
• Dupilumab therapy · National Medical Research Center for Children's Health, Russian Federation
• Dupilumab therapy · National Medical Research Center for Children's Health, Russian Federation
• Dupilumab therapy · National Medical Research Center for Children's Health, Russian Federation
• Veklury · ANRS, Emerging Infectious Diseases
• Raltegravir (Use RAL as a simplification strategy) · Hospital Carlos III, Madrid
• Amnio-Maxx® Dual Layer Amnion Patch · Royal Biologics
• Amnio-Maxx® Dual Layer Amnion Patch · Royal Biologics
• Blinded clopidogrel · VA Office of Research and Development
• recombinant B-type, natriuretic peptide · University of Texas Southwestern Medical Center
• recombinant B-type, natriuretic peptide · University of Texas Southwestern Medical Center
• Different Antibiotic Combinations · Inonu University
• Different Antibiotic Combinations · Inonu University
• Different Antibiotic Combinations · Inonu University
• Pf-07853578 · Pfizer
• Pf-07853578 · Pfizer
• Fentanyl (F2) · Oslo University Hospital
• Fentanyl (F2) · Oslo University Hospital
• Intravenous Ketamine · Rebecca Price
• Intravenous Ketamine · Rebecca Price
• Oral Viscous Budesonide (OVB) · Azienda Policlinico Umberto I
• Liposomal doxorubicin hydrochloride · Cephalon, Inc.
• Liposomal doxorubicin hydrochloride · Cephalon, Inc.
• rFVIIa, rFVIIa + TXA · Oslo University Hospital
• rFVIIa, rFVIIa + TXA · Oslo University Hospital
• rFVIIa, rFVIIa + TXA · Oslo University Hospital
• Chorionic Gonadotropin, Alpha · Copenhagen University Hospital at Herlev
• Chorionic Gonadotropin, Alpha · Copenhagen University Hospital at Herlev
• semaglutide or tirzepatide · Mayo Clinic
• Talazoparib with enzalutamide · Pfizer
• Test formulation (Treatment A) · Pfizer

Competitive intelligence

For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:

• Unknown indication patent landscape — cliff calendar, originator estates, attackable patents
• Unknown indication treatment landscape brief
• Unknown indication treatment updates RSS

Frequently asked questions about Unknown indication

Related

• Treatment landscape: Unknown indication patent cliff · Unknown indication CI report
• Treatment: omeprazole, 20mg twice daily · Tel-Aviv Sourasky Medical Center
• Treatment: omeprazole, 20mg twice daily · Tel-Aviv Sourasky Medical Center
• Treatment: omeprazole, 20mg twice daily · Tel-Aviv Sourasky Medical Center
• Treatment: 0.33% ropivacaine 250ml · Guangzhou General Hospital of Guangzhou Military Command
• Treatment: 0.33% ropivacaine 250ml · Guangzhou General Hospital of Guangzhou Military Command
• All diseases: Browse the disease index · Disease landscape hub

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing